Why don't we get anything done anymore?
With endless meetings, incessant emails, and casts of thousands, companies have mastered the art of unnecessary interactions. Winning in...
news
The bonus quandary - and why you don't want to be 'normal'
There’s a topic that’s come up over and again in the past few weeks - the question of compensation for members of your medical department...
Dying ideas...
Don't let great ideas die over and over again because they're not being sold well. ___ This is part of a series of posts by LUCENT...
Tired predictions and 'the end of the salesforce era'
You don’t need to look far to find predictions of ‘the end of the sales-force era’ in biopharma. I first heard this in February 2004...
Co-creation?
It came up again in conversations yesterday – ‘co-creation’ – that elusive beast that forms so much of medico-marketing planning. For the...
Enter the 'Super Medic'
Like so many things in business (and in life), when you distill down far enough you reach the same conclusion - it's about the people....
Rise of the customer experience
The pharma industry has long recognised the need to move from product- based selling to more customer-centric and value-based...
Leadership is broken
The perceived wisdom about leaders, their characteristics and the development of those traits is wrong. One only has to look at the...
Customer experience in prescription medicines
A succession of poor product launches in the biopharma world leads McKinsey to postulate that the focus on the product alone could be...
Digital Marketing to Physicians
Digital marketing in biopharma has moved on a lot in the past ten years - it needed to - it was already ten years behind comparable...
Medical Affairs in 2025
The summary: 1. Medical Affairs is underutilised 2. Medical Affairs occupies a unique position in the business that would allow it to...
Biopharma predictions 2022
If you haven't already heard of Paul Simms before, chances are you'll have heard of one or two of his predictions for the industry, which...